Products

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester is a complex chemical compound that has shown potential in various areas of medicinal chemistry and drug discovery. Here is a description of its uses in about 300 words.This compound, often referred to as the ethyl ester derivative of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid, belongs to the class of pyrazolo[3,4-c]pyridine derivatives. These derivatives have attracted attention in drug discovery due to their potential in various therapeutic areas.One potential application of this compound lies in the field of anti-cancer research. Pyrazolo[3,4-c]pyridine derivatives have exhibited promising anti-proliferative activity against several types of cancer cells. Their ability to inhibit specific pathways involved in tumor growth and survival makes them potential candidates for the development of anti-cancer drugs. Further studies are needed to explore the mechanism of action and evaluate the compound's efficacy in preclinical and clinical settings.Moreover, this compound has shown promise as a potential antibacterial agent. It has exhibited activity against various strains of bacteria, including both Gram-positive and Gram-negative bacteria. The ability to target multiple strains suggests its potential in combating drug-resistant bacteria, which have become a significant global health concern. Further research is warranted to investigate its mode of action and assess its effectiveness in combating bacterial infections.Additionally, pyrazolo[3,4-c]pyridine derivatives, including this compound, have demonstrated potential in the treatment of inflammatory and autoimmune diseases. Inflammation plays a critical role in various conditions such as rheumatoid arthritis and psoriasis. These derivatives have exhibited anti-inflammatory properties by modulating specific pathways involved in the inflammatory response. This suggests their potential as therapeutic agents for managing chronic inflammation and associated diseases.Furthermore, this compound has shown activity in the central nervous system (CNS). It has been investigated for its potential in neurological disorders such as Alzheimer's disease and Parkinson's disease. The compound may modulate specific receptors and enzymes involved in disease progression, potentially offering neuroprotective effects. However, further research is needed to fully understand its mechanism of action and assess its efficacy in treating these complex disorders.In summary, 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester holds promise in several therapeutic areas, including anti-cancer, antibacterial, anti-inflammatory, and CNS disorders. Its potential lies in its ability to target specific pathways and receptors involved in these conditions. However, further research and investigation are necessary to fully explore its potential, optimize its properties, and assess its safety and efficacy in clinical settings.